- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04339803
Dose-Finding of Lower Limb Mirror Therapy After Stroke.
Study Overview
Detailed Description
Procedure:a 3+3 rule-based, dose-escalation design (Colucci et al,2017). recruitment process: the study will begin with a cohort of three participants (n=3). Each of the subsequent cohorts will also be of three participants. The start dose will be set at 15 minutes (cohort one). Participants will do ankle dorsiflexion exercise at the set dose with the mirror for two weeks. The second and subsequent cohorts will exercise at dose set in accordance to the nine preset rules and the modified Fibonacci sequence (mFBS) .
Sample size: The target sample size is not usually predefined for a dose-finding study. The final sample size will be determined by the response of consecutive cohorts to the set dose. Usually, in pharmaceutical dose-finding studies, the sample size lies between 12 and 40.
Data analysis : The data for each cohort will be analysed using descriptive statistics. No significance testing is involved.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Norwich, United Kingdom, NR4 7TJ
- Sarah Bajuaifer
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants have had a stroke for six weeks or more before recruitment to this study, and are discharged from NHS statutory stroke rehabilitation.
- Participants will be at least 18 years of age
- Able to produce some voluntary contraction of paretic ankle ( motricity index between 9 and 19).
- Ability to understand and follow simple verbal instructions (one-stage commands), i.e. sufficient communication, orientation, and memory to participate in mirror therapy ankle exercise.
- Participants will have had no lower limb injury in the last six months and were able to walk independently indoors before the index stroke.
Exclusion Criteria:
- Foot or ankle contracture that prevents 50% of the passive range of motion.
- Any condition that can be exaggerated by performing the therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: mirror therapy
lower limb mirror therapy using ankle exercise
|
we use lower limb mirror therapy after stroke for two weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in the Motricity Index
Time Frame: Baseline, 2 weeks.
|
Baseline, 2 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the Symmetry
Time Frame: Baseline, 2 weeks
|
in Tibialis anterior muscle activation between the more and less paretic leg
|
Baseline, 2 weeks
|
|
Changes in the Neural excitability
Time Frame: Baseline, 2 weeks
|
at the spinal level using peripheral nerve stimulation-H reflex
|
Baseline, 2 weeks
|
|
changes in the Transcranial magnetic stimulation (TMS)
Time Frame: Baseline, 2 weeks
|
Corticospinal tract excitability
|
Baseline, 2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Valerie Pomeroy, Professor, School of Health Sciences, University of East Anglia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 255913
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on rehabilitation intervention
-
University of North Carolina, Chapel HillUnited States Department of Defense; Foundation of Hope, North CarolinaCompletedTraumatic Brain Injury | Posttraumatic Stress DisorderUnited States
-
University of DelawareUniversity of Pittsburgh; Duke University; National Institute on Aging (NIA)CompletedOsteoarthritis | Chronic Low-back Pain | Hip Impairments | Hip-spine SyndromeUnited States
-
Université de SherbrookeActive, not recruiting
-
Oslo Metropolitan UniversitySophies Minde Foundation; UniCare Bakke ASCompleted
-
Associazione Italiana Ematologia Oncologia PediatricaRecruitingRehabilitation | Pediatric Cancer | Physical Therapy | Pediatric Oncology | Pediatric Cancer Patients | Motor OutcomesItaly
-
Holland Bloorview Kids Rehabilitation HospitalRecruiting
-
Simon Fraser UniversityCompletedObesity | Cardiovascular Disease | DyslipidemiaCanada
-
Casa di Cura IGEAUniversity of Milano BicoccaRecruitingMild Cognitive Impairment (MCI)Italy
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Royal College of Surgeons, IrelandNot yet recruitingStroke | Cognitive Impairment | Stroke Sequelae